advertisement

Topcon

Ophthalmic Genetics 22

Showing records 1 to 22 | Display all abstracts in Ophthalmic Genetics

106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Pike S
Ophthalmic Genetics 2022; 43: 855-861
106249 Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
Cherkas E
Ophthalmic Genetics 2022; 43: 736-741
106660 Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature
Bhate M
Ophthalmic Genetics 2022; 0: 1-3
106249 Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
Cherkas E
Ophthalmic Genetics 2022; 43: 736-741
106179 Association of osteogenesis imperfecta and glaucoma: case report
Alpogan O
Ophthalmic Genetics 2022; 0: 1-5
105950 Screening of candidate genes at GLC3B and GLC3C loci in Chinese primary congenital glaucoma patients with targeted next generation sequencing
Qiao Y; Shao T
Ophthalmic Genetics 2022; 0: 1-6
106660 Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature
Fernandes M
Ophthalmic Genetics 2022; 0: 1-3
106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Iyengar R
Ophthalmic Genetics 2022; 43: 855-861
106249 Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
Negretti GS
Ophthalmic Genetics 2022; 43: 736-741
106660 Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature
Senthil S
Ophthalmic Genetics 2022; 0: 1-3
105950 Screening of candidate genes at GLC3B and GLC3C loci in Chinese primary congenital glaucoma patients with targeted next generation sequencing
Chen Y
Ophthalmic Genetics 2022; 0: 1-6
106249 Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
Zeiger JS
Ophthalmic Genetics 2022; 43: 736-741
106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Peng CC
Ophthalmic Genetics 2022; 43: 855-861
106249 Iris melanoma outcomes based on the Cancer Genome Atlas (TCGA) classification in 78 consecutive patients
Shields CL
Ophthalmic Genetics 2022; 43: 736-741
106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Chevez-Barrios P
Ophthalmic Genetics 2022; 43: 855-861
105950 Screening of candidate genes at GLC3B and GLC3C loci in Chinese primary congenital glaucoma patients with targeted next generation sequencing
Chen J
Ophthalmic Genetics 2022; 0: 1-6
106660 Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature
Bathula S
Ophthalmic Genetics 2022; 0: 1-3
105950 Screening of candidate genes at GLC3B and GLC3C loci in Chinese primary congenital glaucoma patients with targeted next generation sequencing
Sun X
Ophthalmic Genetics 2022; 0: 1-6
106660 Progeroid syndrome of De Barsy - a case report and review of ophthalmic literature
Beilur S
Ophthalmic Genetics 2022; 0: 1-3
106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Brown B
Ophthalmic Genetics 2022; 43: 855-861
105950 Screening of candidate genes at GLC3B and GLC3C loci in Chinese primary congenital glaucoma patients with targeted next generation sequencing
Chen X
Ophthalmic Genetics 2022; 0: 1-6
106228 Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA
Shah R; Biegel J; Yellapantula V; Nagiel A; Reiser BJ; Xu L; Berry JL; Berry JL
Ophthalmic Genetics 2022; 43: 855-861

Issue 23-3

Change Issue


advertisement

Oculus